NASDAQ : AMPH
Amphastar Pharmaceuticals, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 27.72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.15B |
| Enterprise Value | 1.55B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 42.54M |
| Shares Outstanding | 42.54M |
| Shares Change (YoY) | -7.79% |
| Shares Change (QoQ) | -4.81% |
| Owned by Insiders (%) | 10.36% |
| Owned by Institutions (%) | 68.06% |
| Float | 31.29M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 16.02 |
| Forward PE | 8.52 |
| PS Ratio | 1.59 |
| Forward PS | 1.50 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 9.63 |
| P/FCF Ratio | 7.58 |
| P/OCF Ratio | 6.28 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 19.83 |
| EV / Sales | 2.13 |
| EV / EBITDA | 8.01 |
| EV / EBIT | 11.34 |
| EV / FCF | 10.19 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.40 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 4.50 |
| Interest Coverage | 6.32 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.30% |
| Return on Assets (ROA) | 5.11% |
| Return on Invested Capital (ROIC) | 9.06% |
| Return on Capital Employed (ROCE) | 9.28% |
| Weighted Average Cost of Capital (WACC) | 6.81% |
| Revenue Per Employee | $369,443 |
| Profits Per Employee | $39,751 |
| Employee Count | 1,976 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.06 |
Taxes
| Measure | Value |
|---|
| Income Tax | 23.48M |
| Effective Tax Rate | 23.01% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +6.00% |
| 50-Day Moving Average | 24.87 |
| 200-Day Moving Average | 22.25 |
| Relative Strength Index (RSI) | 59.80 |
| Average Volume (20 Days) | 401,030 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.33M |
| Short Previous Month | 4.41M |
| Short % of Shares Out | 10.19% |
| Short % of Float | 13.85% |
| Short Ratio (days to cover) | 8.22 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 730.02M |
| Gross Profit | 348.11M |
| Operating Income | 137.39M |
| Pretax Income | 102.02M |
| Net Income | 78.55M |
| EBITDA | 194.51M |
| EBIT | 137.39M |
| Earnings Per Share (EPS) | $1.69 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 290.12M |
| Total Debt | 688.32M |
| Net Cash | -398.20M |
| Net Cash Per Share | -$9.36 |
| Equity (Book Value) | 768.16M |
| Book Value Per Share | 18.06 |
| Working Capital | 367.75M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 184.61M |
| Capital Expenditures | -31.72M |
| Depreciation & Amortization | 57.13M |
| Net Borrowing | -257,000 |
| Free Cash Flow | 152.89M |
| FCF Per Share | $3.59 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.68% |
| Operating Margin | 18.82% |
| Pretax Margin | 13.98% |
| Profit Margin | 10.76% |
| EBITDA Margin | 26.65% |
| EBIT Margin | 18.82% |
| FCF Margin | 20.94% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.79% |
| Shareholder Yield | 7.79% |
| Earnings Yield | 6.24% |
| FCF Yield | 13.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $22.50 |
| Price Target Difference | -16.76% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 3.91% |
| EPS Growth Forecast (3Y) | 1.19% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |